|
year2004 |
The company was established with a registered capital of 5 million yuan |
|
Year2009 |
Recognized as "National High-tech Enterprise"
Obtained medicine production license
|
|
year2010
|
The company was selected as the first batch of "G20 potential enterprises" in Beijing Company registered capital increased to 200 million yuan
|
|
year2011
|
Beijing Municipal Government awarded the "Beijing Key Laboratory of New Technology Research on Vaccine Combination" "Acellular Haemophilus influenzae type b combined vaccine" won the third prize of Beijing Science and Technology Award
|
|
year2012
|
Beijing Municipal Government awarded "Beijing Engineering Laboratory for New Vaccines" Two vaccine varieties independently developed by the company obtained GMP certificate Won the title of "Excellent Enterprise" in the first China Innovation and Entrepreneurship Competition
|
|
year 2013
|
The Ministry of Human Resources and Health approved the establishment of a "postdoctoral research station" Obtained GMP certificate for measles and rubella combined live attenuated vaccine
|
|
Year 2014
|
Beijing Municipal Science and Technology Commission recognizes "new vaccine Beijing International Science and Technology Cooperation Base" Beijing Science and Technology Association approved the establishment of "Academician Expert Workstation" Beijing Municipal Science and Technology Commission recognized "Beijing Engineering Technology Research Center for New Joint Vaccine" Beijing Intellectual Property Office recognized "Beijing Patent Demonstration Unit" Haemophilus influenzae type b conjugate vaccine (pre-filled) obtained GMP certificate
|
|
2015
|
National Development and Reform Commission recognized "National and Local Joint Engineering Laboratory for New Vaccine Development Technology" Passed the review of "National High-tech Enterprise"
|
|
|